STOCK TITAN

SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SomaLogic announced its participation in the Cowen 42nd Annual Health Care Conference on March 9, 2022, scheduled for 11:10 a.m. Eastern Time. The event will feature a fireside chat where company's management will discuss key developments. Interested individuals can access both live and archived sessions through the ‘Investors’ section of SomaLogic's website. The company, listed under Nasdaq: SLGC, specializes in AI-driven proteomics technology aimed at providing actionable health information.

Positive
  • None.
Negative
  • None.

BOULDER, Colo., Feb. 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the Cowen 42nd Annual Health Care Conference.

SomaLogic management is scheduled to participate in a fireside chat on Wednesday, March 9, 2022, at 11:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the virtual session on the “Investors” section of the company’s website at: https://investors.somalogic.com/events-and-presentations.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

SomaLogic Contact        
Emilia Costales
720-798-5054
ecostales@somalogic.com

Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@somalogic.com


FAQ

When is SomaLogic participating in the Cowen 42nd Annual Health Care Conference?

SomaLogic will participate in the Cowen 42nd Annual Health Care Conference on March 9, 2022, at 11:10 a.m. Eastern Time.

How can I access the SomaLogic event at the Cowen Health Care Conference?

You can access the live and archived webcast of the SomaLogic event through the 'Investors' section of their website.

What is the focus of SomaLogic's technology?

SomaLogic focuses on AI-driven proteomics technology that provides precise health-management information.

What is the stock symbol for SomaLogic?

The stock symbol for SomaLogic is SLGC.

Is the SomaScan Platform approved for patient management?

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. FDA for diagnostic or patient management purposes.

SomaLogic, Inc.

NASDAQ:SLGC

SLGC Rankings

SLGC Latest News

SLGC Stock Data

396.23M
175.53M
2.16%
61.71%
3.79%
Health Information Services
Healthcare
Link
United States
Boulder